|
Expression of GHRH-R, a Potentially Targetable Biomarker, in Triple-negative Breast Cancer
|
01 February 2019 |
|
RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model
|
01 February 2019 |
|
Vitamin C as a Modulator of the Response to Cancer Therapy
|
01 February 2019 |
|
Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells
|
28 January 2019 |
|
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma
|
25 January 2019 |
|
Melatonin regulates tumor aggressiveness under acidosis condition in breast cancer cell lines
|
25 January 2019 |
|
Tocotrienols Modulate a Life or Death Decision in Cancers
|
25 January 2019 |
|
Five Year-Survival with High-Dose Melatonin and Other Antitumor Pineal Hormones in Advanced Cancer Patients Eligible for the Only Palliative Therapy
|
21 January 2019 |
|
Metformin and melatonin improve histopathological outcome of NMU-induced mammary tumors in rats
|
18 January 2019 |
|
Melatonin and its anti-glioma functions: a comprehensive review
|
18 January 2019 |